Showing results (121-130 of 238) with videos related to
Sort By:
Pageof 24
Archives of Internal Medicine|April 1, 1991
Afibrinogenemia and hypobetalipoproteinemia in a kindredD M Lane, W J McConathy, P C Comp, et al.The American Journal of Cardiology|November 1, 1996
Monitoring low-dose warfarin therapy by a central laboratory and implications for clinical trials and patient care. The Coumadin Aspirin Reinfarction (CARS) Pilot Study GroupG E Raskob, S S Durica, W L Owen, et al.Blood|February 1, 1993
Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activationJ H Morrissey, B G Macik, P F Neuenschwander, et al.Proceedings of the National Academy of Sciences of the United States of America|December 26, 2001
Age and stage dependency of estrogen receptor expression by lymphocyte precursorsH Igarashi, T Kouro, T Yokota, et al.The Journal of Clinical Investigation|July 15, 1997
Identification of functional endothelial protein C receptor in human plasmaS Kurosawa, D J Stearns-Kurosawa, N Hidari, et al.Journal of Thrombosis and Haemostasis : JTH|July 30, 2014
Histones induce phosphatidylserine exposure and a procoagulant phenotype in human red blood cellsF Semeraro, C T Ammollo, N L Esmon, et al.The Journal of Biological Chemistry|January 15, 1986
Cultured bovine aortic endothelial cells promote activated protein C-protein S-mediated inactivation of factor VaD M Stern, P P Nawroth, K Harris, et al.Haematologica|May 18, 1999
Lupus anticoagulants, thrombosis and the protein C systemN L Esmon, M D Smirnov, O Safa, et al.Biochemistry|February 23, 1999
Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein CO Safa, J H Morrissey, C T Esmon, et al.Journal of Autoimmunity|September 2, 2000
Antiphospholipid antibodies and the protein C pathwayN L Esmon, O Safa, M D Smirnov, et al.Pageof 24